Delirium in the ICU: An overview

Annals of Intensive Care

Volumn 2, Issue 1, 2012, Pages 1-11

  Cavallazzi, Rodrigo ^a   Saad, Mohamed ^a   Marik, Paul E ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Antipsychotics; Coma; Critical illness; Delirium; Sedatives

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ALCOHOL; AMFEBUTAMONE; BENZODIAZEPINE; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CHLORPROMAZINE; CYTOKINE; DEXMEDETOMIDINE; DOPAMINE; GELATINASE B; HALOPERIDOL; HYDROCORTISONE; LORAZEPAM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURON SPECIFIC ENOLASE; NEUROTOXIN; OLANZAPINE; PLACEBO; PROCALCITONIN; PROPOFOL; PROTEIN C; PROTEIN S100B; QUETIAPINE; TRYPTOPHAN; TUMOR NECROSIS FACTOR RECEPTOR 1; UNINDEXED DRUG; ZIPRASIDONE;

ABBREVIATED COGNITIVE TEST FOR DELIRIUM; AGITATION; ALCOHOL WITHDRAWAL; ARTICLE; ARTIFICIAL VENTILATION; BLOOD BRAIN BARRIER; BRADYCARDIA; BRAIN DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; COGNITIVE DEFECT; CONFUSION ASSESSMENT METHOD FOR THE ICU; CONFUSION ASSESSMENT METHOD FOR THE INTENSIVE CARE UNIT; CONSCIOUSNESS LEVEL; CRITICALLY ILL PATIENT; DELIRIUM; DELIRIUM DETECTION SCORE; DELUSION; DISEASE DURATION; DISEASE SEVERITY; DISORIENTATION; DOPAMINERGIC SYSTEM; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; EPIDEMIOLOGY; EXTRAPYRAMIDAL SYMPTOM; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HALLUCINATION; HUMAN; HYPERTENSION; HYPOTENSION; INFLAMMATION; INSOMNIA; INTENSIVE CARE; INTENSIVE CARE DELIRIUM SCREENING CHECKLIST; IRRITABILITY; LENGTH OF STAY; LIGHT EXPOSURE; LOADING DRUG DOSE; MORTALITY; NEELON AND CHAMPAGNE CONFUSION SCALE; NURSING DELIRIUM SCREENING SCALE; OCCUPATIONAL THERAPY; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SENSITIVITY AND SPECIFICITY; TACHYCARDIA; TREMOR;

EID: 84875340983     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/2110-5820-2-49     Document Type: Article

References (88)

1. Anonymous Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association; 2000.
2. Liptzin B, Levkoff SE: An empirical study of delirium subtypes. Br J Psychiatry 1992, 161:843-845.
3. Engel GL, Romano J: Delirium, a syndrome of cerebral insufficiency. 1959. J Neuropsychiatry Clin Neurosci 2004, 16(4):526-538.
4. Salluh JI, Soares M, Teles JM, Ceraso D, Raimondi N, Nava VS, Blasquez P, Ugarte S, Ibanez-Guzman C, Centeno JV, Laca M, Grecco G, Jimenez E, Arias-Rivera S, Duenas C, Rocha MG, Delirium Epidemiology in Critical Care Study Group: Delirium epidemiology in critical care (DECCA): an international study. Crit Care 2010, 14(6):R210.
5. Agarwal V, O'Neill PJ, Cotton BA, Pun BT, Haney S, Thompson J, Kassebaum N, Shintani A, Guy J, Ely EW, Pandharipande P: Prevalence and risk factors for development of delirium in burn intensive care unit patients. J Burn Care Res 2010, 31(5):706-715.
6. Roberts B, Rickard CM, Rajbhandari D, Turner G, Clarke J, Hill D, Tauschke C, Chaboyer W, Parsons R: Multicentre study of delirium in ICU patients using a simple screening tool. Aust Crit Care 2005, 18(1):6. 8-9, 11-14 passim.
7. Thomason JW, Shintani A, Peterson JF, Pun BT, Jackson JC, Ely EW: Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care 2005, 9(4):R375-R381.
8. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, Speroff T, Gautam S, Bernard GR, Inouye SK: Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001, 29(7):1370-1379.
9. Van Rompaey B, Schuurmans MJ, Shortridge-Baggett LM, Truijen S, Elseviers M, Bossaert L: A comparison of the CAM-ICU and the NEECHAM Confusion Scale in intensive care delirium assessment: an observational study in non-intubated patients. Crit Care 2008, 12(1):R16.
10. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R: Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001, 286(21):2703-2710.
11. Peterson JF, Pun BT, Dittus RS, Thomason JW, Jackson JC, Shintani AK, Ely EW: Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 2006, 54(3):479-484.
12. Robinson TN, Raeburn CD, Tran ZV, Brenner LA, Moss M: Motor subtypes of postoperative delirium in older adults. Arch Surg 2011, 146(3):295-300.
13. Hshieh TT, Fong TG, Marcantonio ER, Inouye SK: Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci 2008, 63(7):764-772.
14. Han L, McCusker J, Cole M, Abrahamowicz M, Primeau F, Elie M: Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001, 161(8):1099-1105.
15. Flacker JM, Cummings V, Mach JR Jr, Bettin K, Kiely DK, Wei J: The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry 1998, 6(1):31-41.
16. Cerejeira J, Nogueira V, Luis P, Vaz-Serra A, Mukaetova-Ladinska EB: The cholinergic system and inflammation: common pathways in delirium pathophysiology. J Am Geriatr Soc 2012, 60(4):669-675.
17. Girard TD, Ware LB, Bernard GR, Pandharipande PP, Thompson JL, Shintani AK, Jackson JC, Dittus RS, Ely EW: Associations of markers of inflammation and coagulation with delirium during critical illness. Intensive Care Med 2012, 38(12):19651973.
18. Chan CH, Liu HC, Huang MC: Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine. J Clin Psychopharmacol 2006, 26(6):677-679.
19. van Munster BC, de Rooij SE, Yazdanpanah M, Tienari PJ, Pitkala KH, Osse RJ, Adamis D, Smit O, van der Steen MS, van Houten M, Rahkonen T, Sulkava R, Laurila JV, Strandberg TE, Tulen JH, Zwang L, MacDonald AJ, Treloar A, Sijbrands EJ, Zwinderman AH, Korevaar JC: The association of the dopamine transporter gene and the dopamine receptor 2 gene with delirium, a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2010, 153B(2):648-655.
20. Flacker JM, Lipsitz LA: Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol A Biol Sci Med Sci 1999, 54(6):B239-B246.
21. Choudhury M, Hote MP, Verma Y: Serotonin syndrome in a postoperative patient. J Anaesthesiol Clin Pharmacol 2011, 27(2):233-235.
22. Robinson TN, Raeburn CD, Angles EM, Moss M: Low tryptophan levels are associated with postoperative delirium in the elderly. Am J Surg 2008, 196(5):670-674.
23. Pandharipande PP, Morandi A, Adams JR, Girard TD, Thompson JL, Shintani AK, Ely EW: Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. Intensive Care Med 2009, 35(11):1886-1892.
24. Adams Wilson JR, Morandi A, Girard TD, Thompson JL, Boomershine CS, Shintani AK, Ely EW, Pandharipande PP: The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness*. Crit Care Med 2012, 40(3):835-841.
25. Maclullich AM, Ferguson KJ, Miller T, de Rooij SE, Cunningham C: Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res 2008, 65(3):229-238.
26. Davis KM, Wu JY: Role of glutamatergic and GABAergic systems in alcoholism. J Biomed Sci 2001, 8(1):7-19.
27. Kosten TR, O'Connor PG: Management of drug and alcohol withdrawal. N Engl J Med 2003, 348(18):1786-1795.
28. Jain G, Chakrabarti S, Kulhara P: Symptoms of delirium: an exploratory factor analytic study among referred patients. Gen Hosp Psychiatry 2011, 33(4):377-385.
29. Dubin WR, Weiss KJ, Zeccardi JA: Organic brain syndrome. The psychiatric imposter. JAMA 1983, 249(1):60-62.
30. Eidelman LA, Putterman D, Putterman C, Sprung CL: The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 1996, 275(6):470-473.
31. Linnoila M, Mefford I, Nutt D, Adinoff B: NIH conference. Alcohol withdrawal and noradrenergic function. Ann Intern Med 1987, 107(6):875-889.
32. Hall W, Zador D: The alcohol withdrawal syndrome. Lancet 1997, 349(9069):1897-1900.
33. van Eijk MM, van Marum RJ, Klijn IA, de Wit N, Kesecioglu J, Slooter AJ: Comparison of delirium assessment tools in a mixed intensive care unit. Crit Care Med 2009, 37(6):1881-1885.
34. Devlin JW, Fong JJ, Fraser GL, Riker RR: Delirium assessment in the critically ill. Intensive Care Med 2007, 33(6):929-940.
35. Gaudreau JD, Gagnon P, Harel F, Tremblay A, Roy MA: Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manag 2005, 29(4):368-375.
36. Hart RP, Best AM, Sessler CN, Levenson JL: Abbreviated cognitive test for delirium. J Psychosom Res 1997, 43(4):417-423.
37. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y: Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 2001, 27(5):859-864.
38. Immers HE, Schuurmans MJ, van de Bijl JJ: Recognition of delirium in ICU patients: a diagnostic study of the NEECHAM confusion scale in ICU patients. BMC Nurs 2005, 4:7.
39. Otter H, Martin J, Basell K, von Heymann C, Hein OV, Bollert P, Jansch P, Behnisch I, Wernecke KD, Konertz W, Loening S, Blohmer JU, Spies C: Validity and reliability of the DDS for severity of delirium in the ICU. Neurocrit Care 2005, 2(2):150-158.
40. Gaudreau JD, Gagnon P, Harel F, Tremblay A, Roy MA: Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manage 2005, 29(4):368-375.
41. Wei LA, Fearing MA, Sternberg EJ, Inouye SK: The confusion assessment method: a systematic review of current usage. J Am Geriatr Soc 2008, 56(5):823-830.
42. Pun BT, Gordon SM, Peterson JF, Shintani AK, Jackson JC, Foss J, Harding SD, Bernard GR, Dittus RS, Ely EW: Large-scale implementation of sedation and delirium monitoring in the intensive care unit: a report from two medical centers. Crit Care Med 2005, 33(6):1199-1205.
43. Luetz A, Heymann A, Radtke FM, Chenitir C, Neuhaus U, Nachtigall I, von Dossow V, Marz S, Eggers V, Heinz A, Wernecke KD, Spies CD: Different assessment tools for intensive care unit delirium: which score to use? Crit Care Med 2010, 38(2):409-418.
44. Toro AC, Escobar LM, Franco JG, Diaz-Gomez JL, Munoz JF, Molina F, Bejarano J, Yepes D, Navarro E, Garcia A, Wesley Ely E, Esteban A: Spanish version of the CAM-ICU (Confusion Assessment Method for the Intensive Care Unit). Pilot study of validation. Med Intensiva 2010, 34(1):14-21.
45. van Eijk MM, van den Boogaard M, van Marum RJ, Benner P, Eikelenboom P, Honing ML, van der Hoven B, Horn J, Izaks GJ, Kalf A, Karakus A, Klijn IA, Kuiper MA, de Leeuw FE, de Man T, van der Mast RC, Osse RJ, de Rooij SE, Spronk PE, van der Voort PH, van Gool WA, Slooter AJ: Routine use of the confusion assessment method for the intensive care unit: a multicenter study. Am J Respir Crit Care Med 2011, 184(3):340344.
46. Vasilevskis EE, Morandi A, Boehm L, Pandharipande PP, Girard TD, Jackson JC, Thompson JL, Shintani A, Gordon SM, Pun BT, Wesley Ely E: Delirium and sedation recognition using validated instruments: reliability of bedside intensive care unit nursing assessments from 2007 to 2010. J Am Geriatr Soc 2011, 59(Suppl 2):S249-S255.
47. Neto AS, Nassar AP Jr, Cardoso SO, Manetta JA, Pereira VG, Esposito DC, Damasceno MC, Slooter AJ: Delirium screening in critically ill patients: a systematic review and meta-analysis. Crit Care Med 2012, 40(6):1946-1951.
48. Gusmao-Flores D, Figueira Salluh JI, Chalhub RA, Quarantini LC: The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studies. Crit Care 2012, 16(4):R115.
49. Skrobik Y, Ahern S, Leblanc M, Marquis F, Awissi DK, Kavanagh BP: Protocolized intensive care unit management of analgesia, sedation, and delirium improves analgesia and subsyndromal delirium rates. Anesth Analg 2010, 111(2):451-463.
50. Awissi DK, Begin C, Moisan J, Lachaine J, Skrobik Y: I-SAVE study: impact of sedation, analgesia, and delirium protocols evaluated in the intensive care unit: an economic evaluation. Ann Pharmacother 2012, 46(1):21-28.
51. Goncalves CA, Leite MC, Nardin P: Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 2008, 41(10-11):755-763.
52. van Munster BC, Korse CM, de Rooij SE, Bonfrer JM, Zwinderman AH, Korevaar JC: Markers of cerebral damage during delirium in elderly patients with hip fracture. BMC Neurol 2009, 9:21.
53. McGrane S, Girard TD, Thompson JL, Shintani AK, Woodworth A, Ely EW, Pandharipande PP: Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. Crit Care 2011, 15(2):R78.
54. van den Boogaard M, Kox M, Quinn KL, van Achterberg T, van der Hoeven JG, Schoonhoven L, Pickkers P: Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients. Crit Care 2011, 15(6):R297.
55. Grandi C, Tomasi CD, Fernandes K, Stertz L, Kapczinski F, Quevedo J, Dal-Pizzol F, Ritter C: Brain-derived neurotrophic factor and neuronspecific enolase, but not S100beta, levels are associated to the occurrence of delirium in intensive care unit patients. J Crit Care 2011, 26(2):133-137.
56. van Munster BC, Bisschop PH, Zwinderman AH, Korevaar JC, Endert E, Wiersinga WJ, van Oosten HE, Goslings JC, de Rooij SE: Cortisol, interleukins and S100B in delirium in the elderly. Brain Cogn 2010, 74(1):18-23.
57. Lee HB, Mears SC, Rosenberg PB, Leoutsakos JM, Gottschalk A, Sieber FE: Predisposing factors for postoperative delirium after hip fracture repair in individuals with and without dementia. J Am Geriatr Soc 2011, 59(12):2306-2313.
58. Van Rompaey B, Schuurmans MJ, Shortridge-Baggett LM, Truijen S, Bossaert L: Risk factors for intensive care delirium: a systematic review. Intensive Crit Care Nurs 2008, 24(2):98-107.
59. Alagiakrishnan K, Wiens CA: An approach to drug induced delirium in the elderly. Postgrad Med J 2004, 80(945):388-393.
60. Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS, Bernard GR, Ely EW: Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006, 104(1):21-26.
61. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS: Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004, 291(14):1753-1762.
62. Shehabi Y, Riker RR, Bokesch PM, Wisemandle W, Shintani A, Ely EW, SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group: Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med 2010, 38(12):2311-2318.
63. Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH: Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009, 180(11):1092-1097.
64. Lat I, McMillian W, Taylor S, Janzen JM, Papadopoulos S, Korth L, Ehtisham A, Nold J, Agarwal S, Azocar R, Burke P: The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients. Crit Care Med 2009, 37(6):1898-1905.
65. Marquis F, Ouimet S, Riker R, Cossette M, Skrobik Y: Individual delirium symptoms: do they matter? Crit Care Med 2007, 35(11):2533-2537.
66. Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, Gordon SM, Canonico AE, Dittus RS, Bernard GR, Ely EW: Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010, 38(7):1513-1520.
67. van den Boogaard M, Schoonhoven L, Evers AW, van der Hoeven JG, van Achterberg T, Pickkers P: Delirium in critically ill patients: impact on longterm health-related quality of life and cognitive functioning. Crit Care Med 2012, 40(1):112-118.
68. Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999, 340(9):669-676.
69. Wenham T, Pittard A: Intensive care unit environment. CEACCP 2009, 9.
70. Topf M, Bookman M, Arand D: Effects of critical care unit noise on the subjective quality of sleep. J Adv Nurs 1996, 24(3):545-551.
71. Van Rompaey B, Elseviers MM, Van Drom W, Fromont V, Jorens PG: The effect of earplugs during the night on the onset of delirium and sleep perception: a randomized controlled trial in intensive care patients. Crit Care 2012, 16(3):R73.
72. Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, Taichman DB, Dunn JG, Pohlman AS, Kinniry PA, Jackson JC, Canonico AE, Light RW, Shintani AK, Thompson JL, Gordon SM, Hall JB, Dittus RS, Bernard GR, Ely EW: Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008, 371(9607):126-134.
73. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP: Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 373(9678):1874-1882.
74. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA Jr, Murray MJ, Peruzzi WT, Lumb PD, Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002, 30(1):119-141.
75. Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996, 153(2):231-237.
76. Mayo-Smith MF: Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 1997, 278(2):144-151.
77. Venn RM, Hell J, Grounds RM: Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000, 4(5):302-308.
78. Tan JA, Ho KM: Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med 2010, 36(6):926-939.
79. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298(22):2644-2653.
80. Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, Bratty JR, Takala J, Dexmedetomidine for Long-Term Sedation Investigators: Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 2012, 307(11):1151-1160.
81. Bharati S, Pal A, Biswas C, Biswas R: Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: a case series and review of published case reports. Acta Anaesthesiol Taiwan 2011, 49(4):165-167.
82. Gerlach AT, Murphy CV: Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature. Pharmacotherapy 2009, 29(12):1492.
83. Wang W, Li HL, Wang DX, Zhu X, Li SL, Yao GQ, Chen KS, Gu XE, Zhu SN: Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial*. Crit Care Med 2012, 40(3):731-739.
84. Reade MC, O'Sullivan K, Bates S, Goldsmith D, Ainslie WR, Bellomo R: Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care 2009, 13(3):R75.
85. Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, Pun BT, Thompson JL, Shintani AK, Meltzer HY, Bernard GR, Dittus RS, Ely EW, MIND Trial Investigators: Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 2010, 38(2):428-437.
86. Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, Robbins T, Garpestad E: Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebocontrolled pilot study. Crit Care Med 2010, 38(2):419-427.
87. Skrobik YK, Bergeron N, Dumont M, Gottfried SB: Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004, 30(3):444-449.
88. Reade MC: The largest ever trial demonstrating effectiveness of intensive care unit delirium prophylaxis--we must know more! Crit Care Med 2012, 40(8):2540.